C4 Therapeutics, Inc.
CCCC- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001662579
No open-market purchases or sales by C4 Therapeutics, Inc. insiders were filed in the last 90 days; 147 institutions reported holding it in 13F filings for Q2 2026, worth $547.6M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in C4 Therapeutics, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 123
- +23 vs. Q4 2025
- Shares held
- 84.5M
- +9.04M (+12.0%) vs. Q4 2025
- Total value
- $221.3M
- +$77.2M (+53.6%) vs. Q4 2025
- New holders
- 34
- 41 more added
- Sold out
- 11
- 30 more reduced
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CCCC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 147 | $547.6M |
| Q1 2026 | 123 | $221.3M |
| Q4 2025 | 101 | $152.5M |
| Q3 2025 | 97 | $116.6M |
| Q2 2025 | 102 | $78.2M |
| Q1 2025 | 115 | $102.6M |
| Q4 2024 | 113 | $231.8M |
| Q3 2024 | 118 | $365.9M |
| Q2 2024 | 115 | $281.3M |
| Q1 2024 | 106 | $475.6M |
| Q4 2023 | 92 | $265.6M |
| Q3 2023 | 84 | $64.5M |
| Q2 2023 | 100 | $94.1M |
| Q1 2023 | 121 | $117.5M |
| Q4 2022 | 117 | $231.4M |
| Q3 2022 | 114 | $345.9M |
| Q2 2022 | 113 | $297.2M |
| Q1 2022 | 125 | $904.8M |
| Q4 2021 | 119 | $1.15B |
| Q3 2021 | 113 | $1.54B |
| Q2 2021 | 107 | $1.21B |
| Q1 2021 | 83 | $926.8M |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding C4 Therapeutics, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 867,911 | $2.28M | 0.00% | +58,651+7.2% | Added |
| Geode Capital Management, LLC | 951,043 | $2.50M | 0.00% | −37,835−3.8% | Reduced |
| D. E. Shaw & Co., Inc. | 1,060,331 | $2.79M | 0.00% | +1,007,452+1,905.2% | Added |
| Jane Street Group, LLC | 1,246,896 | $3.28M | 0.00% | +372,102+42.5% | Added |
| Susquehanna International Group, LLP | 1,286,840 | $3.38M | 0.00% | −488,943−27.5% | Reduced |
| Millennium Management LLC | 1,393,342 | $3.66M | 0.00% | +204,373+17.2% | Added |
| Acadian Asset Management LLC | 1,890,914 | $4.97M | 0.01% | +1,233,741+187.7% | Added |
| Silverarc Capital Management, LLC | 1,911,785 | $5.03M | 0.59% | −82,439−4.1% | Reduced |
| BlackRock, Inc. | 2,048,526 | $5.39M | 0.00% | +78,712+4.0% | Added |
| Squadron Capital Management LLC | 2,250,000 | $5.92M | 2.37% | +2,250,000 | New |
| Bank of America Corp | 2,359,241 | $6.20M | 0.00% | −28,345−1.2% | Reduced |
| Goldman Sachs Group Inc | 2,387,378 | $6.28M | 0.00% | +1,298,358+119.2% | Added |
| Renaissance Technologies LLC | 2,461,815 | $6.47M | 0.01% | +859,235+53.6% | Added |
| Citadel Advisors LLC | 2,511,015 | $6.60M | 0.00% | +2,063,207+460.7% | Added |
| JPMorgan Chase & Co | 3,223,054 | $7.57M | 0.00% | +3,217,109+54,114.5% | Added |
| Wasatch Advisors Inc | 2,961,761 | $7.79M | 0.05% | −1,383,157−31.8% | Reduced |
| Two Sigma Investments, LP | 3,035,634 | $7.98M | 0.01% | +1,526,031+101.1% | Added |
| Soleus Capital Management, L.P. | 3,803,942 | $10.0M | 0.41% | 00.0% | Unchanged |
| Vanguard Capital Management LLC | 3,861,852 | $10.2M | 0.00% | +3,861,852 | New |
| Lynx1 Capital Management LP | 6,998,902 | $18.4M | 2.91% | −99,231−1.4% | Reduced |
| Bain Capital Life Sciences Investors, LLC | 7,171,910 | $18.9M | 1.70% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 8,000,000 | $21.0M | 0.22% | 00.0% | Unchanged |
| Morgan Stanley | 9,072,400 | $23.9M | 0.00% | +90,738+1.0% | Added |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −1,068,200−100.0% | Sold out |
| ArrowMark Colorado Holdings LLC | 0 | $0 | 0.00% | −204,505−100.0% | Sold out |
| Susquehanna Fundamental Investments, LLC | 0 | $0 | 0.00% | −67,617−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −38,994−100.0% | Sold out |
| Lighthouse Investment Partners, LLC | 0 | $0 | 0.00% | −33,660−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −30,658−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −24,416−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −20,655−100.0% | Sold out |
| Delta Investment Management, LLC | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| R Squared Ltd | 0 | $0 | 0.00% | −13,674−100.0% | Sold out |
| Optima Capital LLC | 0 | $0 | 0.00% | −226−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |